News
This episode of Drug Digest will discuss where the significant bottlenecks are in the development and manufacturing of new ...
Debiopharm further describes AbYlink as a one-step method that results in stable conjugation at defined and invariable sites on the Fc domain of an antibody, with no impact on antigen-binding regions, ...
Under the partnership, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology and will integrate OOC technologies into its R&D platform.
In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...
The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple ...
The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive ...
Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.
The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about the impact of the changing political landscape on ...
How Lonza Capsules & Health Ingredients (CHI) is redefining drug delivery with cutting-edge capsule innovation, ...
Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, ...
Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, development, and manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results